clock.bio is a company headquartered in the United Kingdom. Brouky records 1 investor associated with the company.
clock.bio develops a platform that identifies and validates genetic programs enabling cellular rejuvenation, focusing initially on skin rejuvenation topicals and nutraceuticals to extend human healthspan.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.